News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
21 Results
21 Results
RECOVER’s mid-year milestones: A look at 2025 progress
This year, RECOVER researchers continue to publish results from research studies that deepen our understanding of Long COVID. RECOVER studies continue, with 2 clinical trials expected to reach enrollment goals this summer.
Feature
RECOVER pathobiology studies look inside the body to learn more about Long COVID
RECOVER is funding 60+ pathobiology studies to explore how cells in the body interact with each other to cause Long COVID symptoms. These findings may lead to better ways to diagnose, treat, and prevent Long COVID.
Feature
Collaborating to advance Long COVID research: RECOVER researchers team up across the Pacific Northwest
Five RECOVER study sites across the Pacific Northwest teamed up to form a consortium. Consortium members learn from other RECOVER researchers’ findings and share knowledge with the community.
Feature
R3 Seminar Recap: Persistent SARS-CoV-2 antigens and correlation with Long COVID symptoms: Findings from a multi-cohort study
During the December 10th RECOVER Research Review (R3) Seminar, researchers described a recent pathobiology study investigating viral persistence, or when SARS-CoV-2 remains in a person’s body and continues to cause changes even after they recover from their initial sickness. The study’s findings suggest that viral persistence could be one reason why some people experience certain symptoms of Long COVID.
R3 Seminar Recap
Reviewing RECOVER’s impact in 2024
In 2024, RECOVER continued to advance scientific understanding of Long COVID through observational studies, clinical trials, and community engagement.
Feature
NIH adds funds to Long COVID research, advances work on new clinical trials
The $662 million in funds received in 2024 will ensure that researchers can continue making progress toward understanding, diagnosing, preventing, and treating Long COVID through 2029.
News Release
RECOVER Research Update: November 2024
Recent findings from across RECOVER’s five research areas could improve our ability to identify people with Long COVID, understand the underlying causes of their symptoms, and provide them with care and treatment.
Research Update
RECOVER Research Update: August 2024
Six new RECOVER research publications report findings from the initiative’s pathobiology, observational, and electronic health record (EHR) studies.
Research Update